Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Want to earn quickly? Discover safe ways to earn money fast without scams and secure your finances.
22,263 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
A respected investment firm hints that the crypto market might be near a bottom. Here’s what that could mean for Coin...
A coalition representing the crypto industry files a lawsuit to block Illinois' Digital Asset Tax Act, arguing the le...
A major offshore drilling reshuffle drives Transocean higher as Valaris merges with a multi‑billion agreement. This p...
A new financing path for accessory dwelling units could unlock bigger yields for landlords. This article breaks down ...
SoundHound AI is pursuing an enterprise voice AI niche built on data ownership and brand protection. This article bre...
Anthropic unveils Claude Code Security, an AI system designed to autonomously probe codebases for vulnerabilities, ra...
UnitedHealth stock has lagged in 2026, raising questions about its earnings, growth, and risks. This deep-dive breaks...
Investors chasing income with growth potential often look for a reliable pillar. This elite 5.5%-yielding dividend of...
A new wave of tariff talk harkens back to a controversial era. This piece explains why trump’s tariffs: lesson econom...
CrowdStrike accelerates an acquisition push as Palo Alto Networks doubles down on platform strategy. Both leaders rep...
A practical guide to understanding First Solar's 2025 earnings journey. Learn what drives profits, how to read the gu...